Development Of A Comprehensive Model For Colorectal Cancer Risk Prediction
Funder
National Health and Medical Research Council
Funding Amount
$317,012.00
Summary
Bowel cancer is the second most common cause of cancer death in Australia. While the average lifetime risk is 1 in 20, this is a great difference in individual risks. Screening and early detection can prevent 90% of bowel cancer deaths. We need to know who is at high-risk and therefore can be targeted for screening. In this project, I will develop the first tool that can predict precisely an individual’s personal risk of bowel cancer.
Translating Synchrotron Microbeam Radiation Therapy Into A Clinical Reality For Cancer Patients
Funder
National Health and Medical Research Council
Funding Amount
$337,896.00
Summary
The aim of this project is to translate an experimental radiotherapy technique, known as microbeam radiotherapy, into a clinical reality for the benefit of cancer patients world-wide. I propose to achieve this aim by working at the European Synchrotron Radiation Facility (ESRF) in France. The ESRF is Europe’s most powerful synchrotron light source, where a multi-disciplinary team of scientists and physicians are collaborating to treat the first human cancer patients with synchrotron radiation.
A Prospective Study Of Familial Psychological Adjustment And Service Needs On Completion Of Childhood Cancer Treatment.
Funder
National Health and Medical Research Council
Funding Amount
$307,041.00
Summary
Up to 80% of children with cancer survive into adulthood, yet little research has explored the needs of children and their families when a child completes cancer treatment. This project will describe these needs, and plot distress and resilience in families in the first 12 months after cancer treatment ends. The study will identify predictors of positive and negative outcomes after treatment and develop an intervention to reduce distress and enhance resilience in families after childhood cancer.